Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: A prospective study in an Asian primary care population

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 11, 2005, Pages 1313-1320

  Ho, K Y ^a   Gwee, K A ^a   Khor, C J ^a   Selamat, D S ^a   Wai, C T ^a   Yeoh, K G ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; ASIA; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DYSPEPSIA; EMPIRICISM; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME;

ADULT; AGED; ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 20444466801     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02508.x     Document Type: Article

References (22)

1. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995; 27: 67-70.
2. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589-94.
3. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multi-racial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
4. Lim SL, Goh WT, Lee JJM, Ng TP, Ho KY. Changing prevalence of gastro-oesophageal reflux with changing time: a longitudinal study in an Asian population. J Gastroenterol Hepatol 2005: DOI: 10.1111/j.1400-1746.2005.03887.x
5. Ho KY, Chan YH, Kang JY. Increasing trend of reflux oesophagitis and decreasing trend of Helicobacter pylori infection in patients from a multi-ethnic Asian country. Am J Gastroenterol 2005; DOI: 10.1111/j.1572-0241. 2005. 50138.x
6. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
7. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999; 94: 1434-42.
8. Kroes RM, Numans ME, Jones RH, et al. Gastro-oesophageal reflux disease in primary care. Comparison and evaluation of existing national guidelines and development of uniform European guidelines. Eur J Gen Pract 1999; 5: 88-97.
9. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798-810.
10. Dent J, Brun J, Fendrickc AM, et al., on behalf of the Genval Workshop Group. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44 (Suppl. 2): S1-16.
11. Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004; 19: 357-67.
12. Lin BR, Wong JM, Yang JC, et al. Limited value of typical gastroesophageal reflux disease symptoms to screen for erosive esophagitis in Taiwanese. J Formos Med Assoc 2003; 102: 299-304.
13. Wu JC, Chan FK, Ching JY, et al. Empirical treatment based on 'typical' reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection. Gastrointest Endosc 2002; 55: 461-5.
14. Wai CT, Yeoh KG, Ho KY, et al. Endoscopic yield in Asian patients presenting with dyspepsia. Gastrointest Endosc 2002; 56: 548-51.
15. Ho KY, Kang JY, Lim TP, et al. The effect of test duration on the sensitivity and specificity of ultra-rapid urease test for the detection of Helicobacter pylori infection. Aust N Z J Med 1998; 28: 615-9.
16. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
17. Mantynen T, Farkkila M, Kunnamo I, et al. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260 000 inhabitants. Am J Gastroenterol 2002; 97: 2524-9.
18. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003; 17: 1481-91.
19. Kang JY, Ho KY. Different prevalences of reflux oesophagitis and hiatus hernia among dyspeptic patients in England and Singapore. Eur J Gastroenterol Hepatol 1999; 11: 845-50.
20. Johnsson F, Hatlebakk JG, Klintenberg AC, et al. Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn. Scand J Gastroenterol 2003; 38: 347-53.
21. O'Connor HJ. Helicobacter pylori and gastro-oesophageal reflux disease - clinical implications and management. Aliment Pharmacol Ther 1999; 13: 117-27.
22. Yamamori K, Fujiwara Y, Shiba M, et al. Prevalence of symptomatic gastro-oesophageal reflux disease in Japanese patients with peptic ulcer disease after eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2004; 20 (Suppl. 1): 107-11.